
Avenue Biosciences
Menlo Park, CA, United States · avenuebiosciences.com
Avenue Biosciences develops protein engineering technologies to improve protein secretion, expression, yield, and quality. It serves developers of therapeutic proteins and biotechnology tools, including programs in antibodies, fusion proteins, cell and gene therapies, mRNA therapies, enzymes, and AI-designed proteins. The company is based in Helsinki, Finland and Menlo Park, California.
Their website has a general contact form; we send your quote request through it.
What they offer
Secretory pathway optimization
Engineers secretion to improve production yield and product quality in biologics development.
High-throughput signal peptide screening
Screens large signal peptide libraries customized for a target protein to identify the best-performing signal peptide.
Single-chain screening
Screens signal peptide variants for single-chain therapeutic proteins.
Two-chain screening
Optimizes two chains in combination for balanced assembly, built for formats such as antibodies.
Custom screening
Designs bespoke screens for complex targets such as three-chain or membrane proteins.
Screening in CHO cells
Expresses the library in CHO cells and measures secretion efficiency at the single-cell level.
DNA analysis
Identifies signal peptide–protein combinations that drive the highest secretory output.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, Peptide, mRNA, Cell therapy, Recombinant protein, Biosimilar
- Species and models
- CHO cells
- Assays and studies
- high-throughput screening, signal peptide screening, single-cell secretion assay, NGS analysis, secretion titer analysis, intact-mass analysis, cleavage confirmation by mass spectrometry, SEC-MALS
- Instruments and platforms
- SEC-MALS, mass spectrometry, NGS
- Scale and capacity
- multi-thousand signal peptide library, thousands of signal peptide variants, milliliter to liter volume
- Therapeutic areas
- cancer, infectious diseases, immunology, rare diseases
- What to send
- Target protein sequence · Client objectives for the screen
- Sites
- Helsinki, Finland · Palo Alto, United States · Menlo Park, United States
- Serves
- Europe, USA
- Address
- 2026 Avenue Biosciences Expands Board of Directors with Appointment of Dr. Jens V
- Founded
- 2024
Similar labs. CDI Labs, enGenes, Sai Life, Abeomics
Found in a contract services directory. Listing built from avenuebiosciences.com. Work here? Claim this listing.